Exome Asset Management’s 89bio ETNB Stock Holding History

Exome Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-273,661	Closed	-$4.02M	–	71
2025 Q3	$4.02M	Buy	273,661 +40,235	+17%	+$410K	2.44%	12
2025 Q2	$2.29M	Sell	233,426 -120,456	-34%	-$997K	1.7%	23
2025 Q1	$2.57M	Buy	353,882 +128,559	+57%	+$1.12M	2.29%	20
2024 Q4	$1.76M	Sell	225,323 -75,277	-25%	-$620K	1.32%	33
2024 Q3	$2.22M	Buy	+300,600	New	+$2.53M	1.5%	29

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Exome Asset Management's ETNB Position: Q4 2025 in Review

Exome Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 273,661 shares — an estimated $4.02M sold.

Exome Asset Management first reported a position in ETNB in Q3 2024 and held it in 5 quarters. The position peaked at $4.02M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Exome Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Exome Asset Management sold 273,661 89bio shares in Q4 2025, an estimated $4.02M.
Exome Asset Management first reported a position in 89bio in Q3 2024 and held it in 5 quarters.
Exome Asset Management's 89bio position peaked at $4.02M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Exome Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.